| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 |
|---|---|---|---|---|
| Revenue | 220.5M +9.4% | 201.6M +2.7% | 196.3M +6.6% | 184.2M |
| Cost of Revenue | 57.5M +7.8% | 53.3M +0.5% | 53.1M -31.6% | 77.5M |
| Gross Profit | 163.0M +10.0% | 148.3M +3.5% | 143.3M +34.3% | 106.6M |
| Operating Expenses | 252.8M -1.6% | 257.0M -0.2% | 257.6M -53.5% | 553.6M |
| R&D | 101.8M -3.7% | 105.7M +0.1% | 105.6M -59.8% | 262.7M |
| SG&A | 151.0M -0.2% | 151.3M -0.5% | 152.0M -47.8% | 290.9M |
| Operating Income | -89799000 +17.4% | -108737000 +4.9% | -114286000 +74.4% | -446970000 |
| EBITDA | -94547000 -13.4% | -83342000 +6.8% | -89386000 +80.0% | -446970000 |
| Net Income | -110817000 +4.9% | -116496000 -105.2% | -56770000 +87.5% | -453075000 |
| EPS (Basic) | $-0.27 +6.9% | $-0.29 -107.1% | $-0.14 +92.4% | $-1.85 |
| EPS (Diluted) | $-0.27 +6.9% | $-0.29 -107.1% | $-0.14 +92.4% | $-1.85 |
| Shares (Diluted) | 405.0M +1.1% | 400.5M +0.6% | 398.1M +62.7% | 244.7M |